J Presthus

602 total citations
31 papers, 388 citations indexed

About

J Presthus is a scholar working on Neurology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, J Presthus has authored 31 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Surgery. Recurrent topics in J Presthus's work include Parkinson's Disease Mechanisms and Treatments (11 papers), Neurological disorders and treatments (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (3 papers). J Presthus is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), Neurological disorders and treatments (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (3 papers). J Presthus collaborates with scholars based in Norway, Denmark and Sweden. J Presthus's co-authors include A. Hajba, P. Amundsen, I. O. Skalpe, T. Torbergsen, P Dietrichson, Charles M. Poser, L. R. Gjessing, K. Nordstoga, Inge Bjerkås and H. Pakkenberg and has published in prestigious journals such as Neurology, Electroencephalography and Clinical Neurophysiology and Acta Psychiatrica Scandinavica.

In The Last Decade

J Presthus

29 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Presthus Norway 12 179 94 85 55 40 31 388
P Dietrichson Norway 13 199 1.1× 104 1.1× 34 0.4× 50 0.9× 94 2.4× 33 514
César Tabernero Spain 9 278 1.6× 109 1.2× 41 0.5× 41 0.7× 65 1.6× 14 403
Yahr United States 12 241 1.3× 114 1.2× 16 0.2× 58 1.1× 42 1.1× 32 419
R. R. Strang Sweden 7 147 0.8× 65 0.7× 26 0.3× 41 0.7× 26 0.7× 18 358
C. D’Avino Italy 10 193 1.1× 75 0.8× 31 0.4× 56 1.0× 50 1.3× 12 333
E Csanda Hungary 11 143 0.8× 143 1.5× 29 0.3× 59 1.1× 55 1.4× 36 370
Erna Christensen Denmark 4 98 0.5× 75 0.8× 11 0.1× 78 1.4× 46 1.1× 9 298
P Lamberti Italy 8 275 1.5× 44 0.5× 16 0.2× 29 0.5× 46 1.1× 13 371
Shoko Deguchi Japan 11 106 0.6× 50 0.5× 39 0.5× 29 0.5× 58 1.4× 27 291
Levent Sinan Bir Türkiye 11 80 0.4× 30 0.3× 91 1.1× 75 1.4× 60 1.5× 44 351

Countries citing papers authored by J Presthus

Since Specialization
Citations

This map shows the geographic impact of J Presthus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Presthus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Presthus more than expected).

Fields of papers citing papers by J Presthus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Presthus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Presthus. The network helps show where J Presthus may publish in the future.

Co-authorship network of co-authors of J Presthus

This figure shows the co-authorship network connecting the top 25 collaborators of J Presthus. A scholar is included among the top collaborators of J Presthus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Presthus. J Presthus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dupont, E., Anne‐Marie Nybo Andersen, J. Boas, et al.. (2009). Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients. Acta Neurologica Scandinavica. 93(1). 14–20. 32 indexed citations
2.
Presthus, J, et al.. (2009). APPRAISAL OF LONG-TERM LEVODOPA TREATMENT OF PARKINSONISM WITH SPECIAL REFERENCE TO THERAPY LIMITING FACTORS. Acta Neurologica Scandinavica. 50(6). 774–790. 1 indexed citations
3.
Broman, Tore, et al.. (2009). ASPECTS ON CLASSIFICATION METHODS IN MULTIPLE SCLEROSIS. Acta Neurologica Scandinavica. 41(S13). 543–548. 8 indexed citations
4.
Presthus, J. (2009). MULTIPLE SCLEROSIS IN MØRE OG ROMSDAL COUNTY, NORWAY. Acta Neurologica Scandinavica. 42(S19). 12–18. 11 indexed citations
5.
Presthus, J, et al.. (1987). Selegiline (1-deprenyl) and low-dose levodopa treatment of Parkinson's disease A double-blind crossover trial.. Acta Neurologica Scandinavica. 76(3). 200–203. 10 indexed citations
6.
Amundsen, P., et al.. (1983). Randomized double-blind cross-over study of iohexol and Amipaque in cerebral angiography.. American Journal of Neuroradiology. 4(3). 342–3. 6 indexed citations
7.
Pakkenberg, H., et al.. (1976). PARKINSON'S DISEASE TREATED WITH SINEMET OR MADOPAR. Acta Neurologica Scandinavica. 53(5). 376–385. 18 indexed citations
8.
Dietrichson, P, et al.. (1975). Treatment of Parkinsonism with L-Dopa and a Decarboxylase Inhibitor. European Neurology. 13(4). 339–349. 5 indexed citations
9.
Rinne, U. K., E. Dupont, Estrid Stæhr Hansen, et al.. (1975). Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (madopar®) in the treatment of Parkinson's disease. Journal of Neurology. 211(1). 1–9. 18 indexed citations
10.
Amundsen, P., I. O. Skalpe, J Presthus, T. Torbergsen, & B Kaada. (1975). Metrizamide, the New Water-Soluble Non-Ionic Contrast Medium for Myelography. Acta Radiologica Diagnosis. 16(347_suppl). 453–458. 3 indexed citations
11.
Gjessing, L. R., et al.. (1974). Free Amino Acids in the Cerebrospinal Fluid in Old Age and in Parkinson’s Disease. European Neurology. 12(1). 33–37. 35 indexed citations
12.
Presthus, J, et al.. (1972). Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).. PubMed. 51. 121–2. 1 indexed citations
13.
Presthus, J. (1971). BC 105 AND METHYSERGIDE (DESERIL®) IN MIGRAINE PROPHYLAXIS. Acta Neurologica Scandinavica. 47(4). 514–518. 11 indexed citations
14.
Presthus, J, et al.. (1967). THE SIGNIFICANCE OF ALLERGY IN THE ETIOLOGY AND PATHOGENESIS OF MULTIPLE SCLEROSIS. Acta Neurologica Scandinavica. 43(2). 215–227. 17 indexed citations
15.
Poser, Charles M., et al.. (1966). Clinical characteristics of autopsy‐proved multiple sclerosis. Neurology. 16(8). 791–791. 27 indexed citations
16.
Broman, Tore, et al.. (1965). Panel discussion of 'classification in multiple sclerosis'.. PubMed. 13 Pt 2. 577–9. 1 indexed citations
17.
Refsum, S, et al.. (1960). CLINICAL CORRELATES OF THE 14 AND 6 PER SECOND POSITIVE SPIKES. An Eleclroencephalographic and Clinical Study.. Acta Psychiatrica Scandinavica. 35(3). 330–344. 18 indexed citations
18.
Presthus, J. (1960). REPORT ON THE MULTIPLE SCLEROSIS INVESTIGATIONS IN WEST‐NORWAY. Acta Psychiatrica Scandinavica. 35(S147). 88–92. 30 indexed citations
19.
Presthus, J, et al.. (1957). Cortisone therapy in lupus erythematosus disseminatus with affection of the central nervous system.. PubMed. 77(1). 11–3. 3 indexed citations
20.
Presthus, J. (1953). DIAGNOSTIC PROBLEMS IN TUBEROUS SCLEROSIS. Acta Psychiatrica Scandinavica. 28(1). 81–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026